Eton Pharmaceuticals (ETON) Competitors $20.18 +0.58 (+2.96%) As of 12:40 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ETON vs. TARS, BEAM, APGE, SDGR, CNTA, BHC, ARQT, AGIO, GLPG, and IRONShould you be buying Eton Pharmaceuticals stock or one of its competitors? The main competitors of Eton Pharmaceuticals include Tarsus Pharmaceuticals (TARS), Beam Therapeutics (BEAM), Apogee Therapeutics (APGE), Schrödinger (SDGR), Centessa Pharmaceuticals (CNTA), Bausch Health Companies (BHC), Arcutis Biotherapeutics (ARQT), Agios Pharmaceuticals (AGIO), Galapagos (GLPG), and Disc Medicine (IRON). These companies are all part of the "pharmaceutical products" industry. Eton Pharmaceuticals vs. Tarsus Pharmaceuticals Beam Therapeutics Apogee Therapeutics Schrödinger Centessa Pharmaceuticals Bausch Health Companies Arcutis Biotherapeutics Agios Pharmaceuticals Galapagos Disc Medicine Eton Pharmaceuticals (NASDAQ:ETON) and Tarsus Pharmaceuticals (NASDAQ:TARS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, risk, profitability, earnings, media sentiment, community ranking and analyst recommendations. Is ETON or TARS more profitable? Eton Pharmaceuticals has a net margin of -15.81% compared to Tarsus Pharmaceuticals' net margin of -103.64%. Eton Pharmaceuticals' return on equity of -36.29% beat Tarsus Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Eton Pharmaceuticals-15.81% -36.29% -16.84% Tarsus Pharmaceuticals -103.64%-55.86%-39.28% Do insiders & institutionals have more ownership in ETON or TARS? 27.9% of Eton Pharmaceuticals shares are held by institutional investors. Comparatively, 90.0% of Tarsus Pharmaceuticals shares are held by institutional investors. 16.0% of Eton Pharmaceuticals shares are held by insiders. Comparatively, 8.3% of Tarsus Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Do analysts recommend ETON or TARS? Eton Pharmaceuticals currently has a consensus price target of $29.00, indicating a potential upside of 43.74%. Tarsus Pharmaceuticals has a consensus price target of $66.33, indicating a potential upside of 49.74%. Given Tarsus Pharmaceuticals' higher probable upside, analysts plainly believe Tarsus Pharmaceuticals is more favorable than Eton Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Eton Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Tarsus Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.00 Does the MarketBeat Community believe in ETON or TARS? Eton Pharmaceuticals received 47 more outperform votes than Tarsus Pharmaceuticals when rated by MarketBeat users. However, 67.95% of users gave Tarsus Pharmaceuticals an outperform vote while only 66.23% of users gave Eton Pharmaceuticals an outperform vote. CompanyUnderperformOutperformEton PharmaceuticalsOutperform Votes10066.23% Underperform Votes5133.77% Tarsus PharmaceuticalsOutperform Votes5367.95% Underperform Votes2532.05% Which has higher valuation and earnings, ETON or TARS? Eton Pharmaceuticals has higher earnings, but lower revenue than Tarsus Pharmaceuticals. Eton Pharmaceuticals is trading at a lower price-to-earnings ratio than Tarsus Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEton Pharmaceuticals$48.33M11.20-$940K-$0.18-112.08Tarsus Pharmaceuticals$233.67M7.97-$135.89M-$2.73-16.23 Does the media refer more to ETON or TARS? In the previous week, Eton Pharmaceuticals had 17 more articles in the media than Tarsus Pharmaceuticals. MarketBeat recorded 25 mentions for Eton Pharmaceuticals and 8 mentions for Tarsus Pharmaceuticals. Tarsus Pharmaceuticals' average media sentiment score of 1.54 beat Eton Pharmaceuticals' score of 0.11 indicating that Tarsus Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Eton Pharmaceuticals 5 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Tarsus Pharmaceuticals 8 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has more volatility & risk, ETON or TARS? Eton Pharmaceuticals has a beta of 1.22, indicating that its stock price is 22% more volatile than the S&P 500. Comparatively, Tarsus Pharmaceuticals has a beta of 0.94, indicating that its stock price is 6% less volatile than the S&P 500. SummaryEton Pharmaceuticals beats Tarsus Pharmaceuticals on 10 of the 18 factors compared between the two stocks. Get Eton Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ETON and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ETON vs. The Competition Export to ExcelMetricEton PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$541.30M$6.58B$5.41B$8.53BDividend YieldN/A2.66%5.22%4.11%P/E Ratio-91.759.2126.7719.96Price / Sales11.20257.57395.44121.37Price / Cash4,502.7965.8538.2534.62Price / Book33.636.576.874.60Net Income-$940,000.00$144.25M$3.23B$248.27M7 Day Performance17.84%5.13%5.32%2.28%1 Month Performance41.48%9.67%13.56%16.43%1 Year Performance461.98%-0.88%17.86%8.15% Eton Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ETONEton Pharmaceuticals2.3953 of 5 stars$20.18+2.9%$29.00+43.7%+438.5%$541.30M$48.33M-91.7520Analyst RevisionTARSTarsus Pharmaceuticals3.321 of 5 stars$44.20-1.3%$66.33+50.1%+15.9%$1.86B$233.67M-11.6050Positive NewsBEAMBeam Therapeutics3.1597 of 5 stars$18.24+4.8%$48.75+167.3%-28.5%$1.83B$63.58M-10.36510Positive NewsAPGEApogee Therapeutics2.1728 of 5 stars$39.58+6.1%$94.60+139.0%-23.0%$1.78BN/A-16.3691Positive NewsGap DownSDGRSchrödinger2.9852 of 5 stars$24.17+1.1%$32.80+35.7%-4.7%$1.77B$207.54M-10.33790News CoverageCNTACentessa Pharmaceuticals3.6101 of 5 stars$13.15+6.9%$27.00+105.3%+51.4%$1.75B$6.85M-8.59200Positive NewsInsider TradeAnalyst RevisionGap UpBHCBausch Health Companies4.222 of 5 stars$4.79+4.2%$7.42+55.0%-28.0%$1.73B$9.73B-39.8719,900Positive NewsARQTArcutis Biotherapeutics2.8323 of 5 stars$14.39+6.4%$18.80+30.6%+55.2%$1.72B$212.82M-8.04150News CoverageInsider TradeAGIOAgios Pharmaceuticals4.0573 of 5 stars$29.14+6.7%$56.00+92.2%-9.1%$1.69B$37.04M2.57390Positive NewsAnalyst DowngradeGLPGGalapagos0.4574 of 5 stars$25.07-1.0%$25.33+1.1%-1.0%$1.65B$288.19M0.001,310News CoveragePositive NewsIRONDisc Medicine2.9064 of 5 stars$46.61+5.4%$98.80+112.0%+54.7%$1.61BN/A-11.7130 Related Companies and Tools Related Companies TARS Alternatives BEAM Alternatives APGE Alternatives SDGR Alternatives CNTA Alternatives BHC Alternatives ARQT Alternatives AGIO Alternatives GLPG Alternatives IRON Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ETON) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eton Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eton Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ETON Stock Free ETON Stock Alerts